Joscha Kraske
@joschakraske
Followers
61
Following
388
Media
2
Statuses
12
physician and cancer researcher @NCT_HD / @DKFZ / @uniklinik_hd
Joined December 2021
Very happy to finally share the work which kept us busy for quite some time! -> Radiotherapy induces CXCL8 release from cancer cells and subsequent NK cell recruitment @science_wallet @peterhuber_hd @BoyuLiao
https://t.co/xy9SDe2LjF
science.org
NK cells rely on the chemokine CXCL8 to play a central role in immune responses to radiotherapy in humans.
0
1
15
How can we study the effects of radiation on immune cells in #cancer? Using innovative human pancreatic tumor models, @joschakraske @science_wallet @peterhuber_hd @DKFZ @uniklinik_hd reveal photon and particle radiotherapy induce signals—grouped as modules—that attract immune
1
5
11
Happy to keep this tradition alive and contribute a few kilometers to the #NCTLauf / #nctrun
@NCT_HD @laufendgegenkrebs 🏃➡️☀️
1
0
7
🚨Job Alert🚨 Unser Early Clinical Trial Team der Med. Onkologie am @NCT_HD der @uniklinik_hd wächst! Wir suchen eine Study Nurse (m/w/d) 👩🏻⚕️🧑🏼⚕️👨🏽⚕️ 🧑🤝🧑 junges, dynamisches Team 📈innovative Therapieansätze 🏥 interdisziplinäre Zusammenarbeit https://t.co/5hsTORd0Sz
#jobopening
0
3
6
We urgently have a PhD position to fill in comp. biology to work with single cell genomics to uncover how the immune response helps pancreatic cancer develop. Within amazing SIMMBAP ( https://t.co/0ncYHk3ef6) consortium 🇪🇺🇪🇸🇮🇱🇩🇪 with @DirenaAC & @vincenttianfr. Reach out now!
transcan.eu
It's a collaborative network of ministries, national and regional funding agencies as well as research councils with programmes in translational cancer research.
9
103
186
Proud to share our newest paper that can now already be found on bioRxiv. Thanks a lot to all contributers!
biorxiv.org
During embryogenesis, distinct cardiac cell types form, which shape the structural and functional properties of the heart. How their activity is coordinated is largely unknown. Here we show that...
0
1
11
@DKFZ @NCT_HD and @uniklinik_hd featured our article on #COVID19 @NatureCancer in a more digestible format. Thank you: patients, nurses, @joschakraske, @_A_Schubert, @CThoeringer, @russell_kunes, @halama_immuno, @Zhang_X_W, @am0ck
https://t.co/ABCvgTXcBf
dkfz.de
Does COVID-19 vaccination increase the risk of cancer patients undergoing therapy with immune checkpoint inhibitors to suffer a dangerous immune complication known as a "cytokine release syndrome"? A...
3
2
17
Finally published underlining the safety of COVID-19 vaccination under immune checkpoint therapy, focusing on a specific adverse event: cytokine release syndrome. https://t.co/dpgC4I5Xdn Great experience working cofirst @SunanjayB and Guy Ungerechts. (1/6)
5
20
69
Radiotherapy meets immunotherapy 🧬 #TBThursday to Walle et al. @ScienceAdvances RT may represent a therapeutic strategy to enhance NK cell infiltration, increasing the antitumor activity in patients with irradiated cancer! @science_wallet @joschakraske @BoyuLiao @peterhuber_hd
Reverse translating a clinical trial to xenograft mouse and in vitro models with primary human immune cells we describe a role for CXCL8 in radiation-induced immune responses in humans. Only possible by great @joschakraske @BoyuLiao @peterhuber_hd
https://t.co/W6u10ipPyE 1/6
1
3
8
Reverse translating a clinical trial to xenograft mouse and in vitro models with primary human immune cells we describe a role for CXCL8 in radiation-induced immune responses in humans. Only possible by great @joschakraske @BoyuLiao @peterhuber_hd
https://t.co/W6u10ipPyE 1/6
9
14
43